RCM
DPLO

Riverhead Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Riverhead Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,800
Closed -$22K – 1540
2019
Q1 		$22K Hold
3,800
– – ﹤0.01% 1472
2018
Q4 		$51K Buy
3,800
+600
+19% +$10.1K ﹤0.01% 1414
2018
Q3 		$62K Buy
3,200
+1,100
+52% +$23.4K ﹤0.01% 1466
2018
Q2 		$54K Hold
2,100
– – ﹤0.01% 1454
2018
Q1 		$42K Buy
+2,100
New +$49K ﹤0.01% 1484
2017
Q1 		– Sell
-600
Closed -$8K – 1540
2016
Q4 		$8K Hold
600
– – ﹤0.01% 1478
2016
Q3 		$17K Buy
+600
New +$20.1K ﹤0.01% 1402

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverhead Capital Management's DPLO Position: Q2 2019 in Review

Riverhead Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 3,800 shares — an estimated $22K sold.

Riverhead Capital Management first reported a position in DPLO in Q3 2016 and held it in 7 quarters. The position peaked at $62K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Riverhead Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Riverhead Capital Management sold 3,800 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $22K.
  • Riverhead Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 7 quarters.
  • Riverhead Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $62K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Riverhead Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.